Business Context and Reporting Period
Company: Universal Health Realty Income Trust (UHT)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and nine months ended September 30, 2025
Business Overview: UHT is a Real Estate Investment Trust (REIT) investing in healthcare and human-service facilities, including acute care hospitals, behavioral health hospitals, medical office buildings, and free-standing emergency departments. The Trust is advised by a wholly-owned subsidiary of Universal Health Services, Inc. (UHS), which is also a major tenant.
Key Financial Metrics
| Metric (in thousands, except per share) | Three Months Ended Sept 30, 2025 | Nine Months Ended Sept 30, 2025 |
|---|---|---|
| Total Revenues | $25,302 | $74,718 |
| Net Income | $4,016 | $13,285 |
| Funds From Operations (FFO) | $12,225 | $35,949 |
| FFO per Diluted Share | $0.88 | $2.59 |
| Net Cash Provided by Operating Activities | N/A | $35,495 |
| Total Debt (Credit Agreement + Mortgages) | $375,625 | $375,625 |
| Cash and Cash Equivalents | $6,916 | $6,916 |
| Dividends Paid (Nine Months) | N/A | $30,715 |
Note: Total Debt includes $357.1 million in line of credit borrowings and $18.6 million in mortgage notes payable.
Material Changes vs. Prior Period
- Revenue: Total revenue increased by $808,000 (3.3%) for the quarter and $349,000 (0.5%) for the nine-month period compared to 2024. The quarterly increase was driven by a $275,000 one-time settlement and a $130,000 increase in bonus rental revenue.
- Net Income: Net income remained relatively flat for the quarter ($4.0 million vs. $4.0 million in 2024) but decreased by $1.3 million for the nine-month period ($13.3 million vs. $14.6 million in 2024). The nine-month decline was attributed to a decrease in property income, a one-time property tax reduction in the prior year, and increased interest expense.
- Interest Expense: Net interest expense increased by $282,000 for the nine-month period, primarily due to a decrease in interest rate swap income following the transition of swap agreements in late 2024, partially offset by a lower average effective cost of borrowings.
- Depreciation: The Trust recorded approximately $900,000 in nonrecurring depreciation expense during the third quarter of 2025.
Guidance, Outlook, and Risks
Management Commentary:
- Dividends: The Trust declared and paid dividends of $0.74 per share for the third quarter and $2.215 per share for the nine-month period. Management believes operating cash flows are sufficient to fund dividend payments.
- Capital Resources: As of September 30, 2025, the Trust had $67.9 million of available borrowing capacity under its $425 million Credit Agreement. Management expects to fund capital expenditures and dividends through internally generated cash flow and available debt capacity.
- Construction: In October 2025, the Trust entered into a ground lease to develop a new medical office building in Palm Beach Gardens, Florida, with an estimated cost of $34 million, scheduled for completion in Q3 2026.
Risks and Contingencies:
- Concentration Risk: Approximately 40% of consolidated revenues are derived from UHS-related tenants. Lease renewals and UHS's financial health are critical to future performance.
- Legislative Impact: The "One Big Beautiful Bill Act" (adopted July 4, 2025) imposes work requirements for Medicaid eligibility and limits provider fees, which may reduce operator revenues and increase uncompensated care.
- Interest Rates: Rising interest rates have increased interest expense and could impact the ability to access capital markets on favorable terms.
- Government Shutdown: A federal government shutdown began on October 1, 2025, due to the failure to approve the FY2026 budget, which could materially impact tenant operations.
Key Facts for Investor Verification
- UHS Dependency: Verify the financial stability of Universal Health Services, Inc. (UHS), as it accounts for ~40% of UHT's revenue and serves as the Trust's Advisor.
- Debt Covenants: Confirm continued compliance with Credit Agreement covenants, specifically the Total Leverage ratio (44.0% vs. 60% limit) and Fixed Charge Coverage (3.2x vs. 1.5x minimum).
- Medicaid Legislation: Monitor the impact of the July 2025 Medicaid legislation on UHS's reimbursement rates and patient volumes.
- Interest Rate Swaps: Review the performance of active interest rate swaps (notional amount of $165 million) which currently provide a net asset value of $2.1 million but reduce income compared to prior periods.
- Dividend Coverage: Note that operating cash flow ($35.5 million for nine months) covered dividend payments ($30.7 million) by approximately $4.8 million, but capital expenditures and debt service also draw from liquidity.